IL18 and neoplasm: Regarding RH30, at a high E:T ratio of 5:1, a significant reduction in tumor growth by γδ T cells was seen after all cytokine treatments with TCR stimulus with the combination of IL-2/IL-12/IL-18 leading to the highest reduction of impedance.